TG THERAPEUTICS, INC. Investment Income, Net
TG THERAPEUTICS, INC. (TGTX) reported Investment Income, Net of $46.61 thousand for the 25-month period ending 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2014-03-07
- TG THERAPEUTICS, INC. investment income, net for the quarter ending 2013-12-31 was $15.77K, a 412.61% increase year-over-year.
- TG THERAPEUTICS, INC. investment income, net for the quarter ending 2013-09-30 was $12.38K, a 149.95% increase year-over-year.
- TG THERAPEUTICS, INC. investment income, net for the quarter ending 2013-06-30 was $1.18K, a 71.24% decline year-over-year.
- TG THERAPEUTICS, INC. investment income, net for the quarter ending 2013-03-31 was $1.50K, a 59.05% decline year-over-year.
- TG THERAPEUTICS, INC. investment income, net for fiscal 2013 was $30.82K, a 95.24% increase from fiscal 2012.
- TG THERAPEUTICS, INC. investment income, net for fiscal 2012 was $15.79K.
- TG THERAPEUTICS, INC. investment income, net for fiscal 2011 was $0.00.
| Period end | Investment Income, Net 3 month | Investment Income, Net 3 month as first filed | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month | Investment Income, Net 13 month | Investment Income, Net 15 month | Investment Income, Net 16 month | Investment Income, Net 18 month | Investment Income, Net 19 month | Investment Income, Net 22 month | Investment Income, Net 25 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $15.77K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $28.14K derived: sum of 2 quarters · filed 2014-03-07 | $29.32K derived: sum of 3 quarters · filed 2014-03-07 | $30.82K 10-K · filed 2014-03-07 | $46.61K 10-K · filed 2014-03-07 | |||||||
| 2013-09-30 | $12.38K 10-Q · filed 2013-11-14 | $13.55K derived: sum of 2 quarters · filed 2013-11-14 | $15.05K 10-Q · filed 2013-11-14 | $18.13K derived: sum of 4 quarters · filed 2014-03-07 | $30.84K 10-Q · filed 2013-11-14 | |||||||
| 2013-06-30 | $1.18K 10-Q · filed 2013-08-09 | $2.68K 10-Q · filed 2013-08-09 | $5.75K derived: sum of 3 quarters · filed 2014-03-07 | $10.71K derived: sum of 4 quarters · filed 2014-03-07 | $18.47K 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | $1.50K 10-Q · filed 2013-05-14 | $4.58K derived: sum of 2 quarters · filed 2014-03-07 | $9.53K derived: sum of 3 quarters · filed 2014-03-07 | $13.62K derived: sum of 4 quarters · filed 2014-03-07 | $17.29K 10-Q · filed 2013-05-14 | |||||||
| 2012-12-31 | $3.08K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $8.03K derived: sum of 2 quarters · filed 2014-03-07 | $12.12K derived: sum of 3 quarters · filed 2014-03-07 | $15.79K 10-K · filed 2014-03-07 | $15.79K 10-K · filed 2013-03-21 | |||||||
| 2012-09-30 | $4.95K 10-Q · filed 2013-11-14 | $9.04K derived: sum of 2 quarters · filed 2013-11-14 | $12.71K 10-Q · filed 2013-11-14 | $12.71K derived: sum of 4 quarters · filed 2013-11-14 | $12.71K 10-Q · filed 2012-11-14 | |||||||
| 2012-06-30 | $4.09K 10-Q · filed 2013-08-09 | $7.76K 10-Q · filed 2013-08-09 | $7.76K derived: sum of 3 quarters · filed 2013-08-09 | $7.76K derived: sum of 4 quarters · filed 2013-08-09 | $7.76K 10-Q/A · filed 2012-09-07 | |||||||
| 2012-03-31 | $3.67K 10-Q · filed 2013-05-14 | -$3.67K 10-Q · filed 2012-05-14 | $3.67K derived: sum of 2 quarters · filed 2013-05-14 | $3.67K derived: sum of 3 quarters · filed 2013-05-14 | -$3.67K 10-Q · filed 2012-05-14 | |||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $0.00 derived: sum of 2 quarters · filed 2013-03-21 | $0.00 derived: sum of 3 quarters · filed 2013-03-21 | $0.00 10-K · filed 2013-03-21 | ||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 | $0.00 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |